Skip to main content

Advertisement

Table 7 H2O2 scavenging activity of eugenol derivatives

From: Lead optimization for promising monoamine oxidase inhibitor from eugenol for the treatment of neurological disorder: synthesis and in silico based study

Compound/sample IC50 (µg/mL)a Sr. no IC50 (µg/mL)a
5a 9.156 ± 0.002 13a 26.6 ± 0.544
5b 8.904 ± 0.034 13b 12.5 ± 0.862
7 9.755 ± 0.021 13c 15.7 ± 0.784
9a 9.547 ± 0.051 13d 14.4 ± 0.143
9b 9.393 ± 0.017 16 20.6 ± 0.856
11 10.33 ± 0.022 17 30.4 ± 0.064
Eugenol 9.980 ± 0.012 l-Ascorbic acid 8.121 ± 0.082
  1. aValue are expressed as mean ± SEM, n = 3